APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sicca Syndrome Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sicca Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174035340319 December 2025194 pages

Choose your research edition.

Industry ResearchSicca Syndrome Drug Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Sicca Syndrome Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Sicca Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sicca Syndrome Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sicca Syndrome Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Sicca Syndrome Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sicca Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sicca Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sicca Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sicca Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sicca Syndrome Drug include Novartis AG, GlaxoSmithKline Plc, Biogen, Inc., Amgen Inc., UCB S.A., Toleranzia AB, Redx Pharma Plc, MedImmune, LLC and Bristol-Myers Squibb Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sicca Syndrome Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sicca Syndrome Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sicca Syndrome Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sicca Syndrome Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Sicca Syndrome Drug Segment by Company

Novartis AG

GlaxoSmithKline Plc

Biogen, Inc.

Amgen Inc.

UCB S.A.

Toleranzia AB

Redx Pharma Plc

MedImmune, LLC

Bristol-Myers Squibb Company

Ampio Pharmaceuticals, Inc.

Akari Therapeutics, Plc

Sicca Syndrome Drug Segment by Type

BMS-986142

Coversin

Filgotinib

Belimumab

LY-3090106

Others

Sicca Syndrome Drug Segment by Application

Hospital

Clinic

Others

Sicca Syndrome Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sicca Syndrome Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sicca Syndrome Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sicca Syndrome Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sicca Syndrome Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sicca Syndrome Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sicca Syndrome Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sicca Syndrome Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sicca Syndrome Drug Industry Trends Table 2. Sicca Syndrome Drug Industry Drivers Table 3. Sicca Syndrome Drug Industry Opportunities and Challenges Table 4. Sicca Syndrome Drug Industry Restraints Table 5. Global Sicca Syndrome Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sicca Syndrome Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sicca Syndrome Drug Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Sicca Syndrome Drug Sales Market Share by Manufacturers Table 9. Global Sicca Syndrome Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Sicca Syndrome Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sicca Syndrome Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sicca Syndrome Drug Manufacturers, Product Type & Application Table 13. Global Sicca Syndrome Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sicca Syndrome Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of BMS-986142 Table 17. Major Manufacturers of Coversin Table 18. Major Manufacturers of Filgotinib Table 19. Major Manufacturers of Belimumab Table 20. Major Manufacturers of LY-3090106 Table 21. Major Manufacturers of Others Table 22. Global Sicca Syndrome Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Sicca Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 24. Global Sicca Syndrome Drug Sales by Type (2027-2032) & (W Units) Table 25. Global Sicca Syndrome Drug Sales Market Share by Type (2021-2026) Table 26. Global Sicca Syndrome Drug Sales Market Share by Type (2027-2032) Table 27. Global Sicca Syndrome Drug Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 28. Global Sicca Syndrome Drug Revenue by Type (2021-2026) & (W Units) Table 29. Global Sicca Syndrome Drug Revenue by Type (2027-2032) & (W Units) Table 30. Global Sicca Syndrome Drug Revenue Market Share by Type (2021-2026) Table 31. Global Sicca Syndrome Drug Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Clinic Table 34. Major Manufacturers of Others Table 35. Global Sicca Syndrome Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Sicca Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 37. Global Sicca Syndrome Drug Sales by Application (2027-2032) & (W Units) Table 38. Global Sicca Syndrome Drug Sales Market Share by Application (2021-2026) Table 39. Global Sicca Syndrome Drug Sales Market Share by Application (2027-2032) Table 40. Global Sicca Syndrome Drug Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 41. Global Sicca Syndrome Drug Revenue by Application (2021-2026) & (W Units) Table 42. Global Sicca Syndrome Drug Revenue by Application (2027-2032) & (W Units) Table 43. Global Sicca Syndrome Drug Revenue Market Share by Application (2021-2026) Table 44. Global Sicca Syndrome Drug Revenue Market Share by Application (2027-2032) Table 45. Global Sicca Syndrome Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 46. Global Sicca Syndrome Drug Sales by Region (2021-2026) & (W Units) Table 47. Global Sicca Syndrome Drug Sales Market Share by Region (2021-2026) Table 48. Global Sicca Syndrome Drug Sales Forecasted by Region (2027-2032) & (W Units) Table 49. Global Sicca Syndrome Drug Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Sicca Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. North America Sicca Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 52. North America Sicca Syndrome Drug Sales by Country (2027-2032) & (W Units) Table 53. Europe Sicca Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Europe Sicca Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 55. Europe Sicca Syndrome Drug Sales by Country (2027-2032) & (W Units) Table 56. Asia Pacific Sicca Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. Asia Pacific Sicca Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 58. Asia Pacific Sicca Syndrome Drug Sales by Country (2027-2032) & (W Units) Table 59. South America, Middle East and Africa Sicca Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 60. South America, Middle East and Africa Sicca Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 61. South America, Middle East and Africa Sicca Syndrome Drug Sales by Country (2027-2032) & (W Units) Table 62. Global Sicca Syndrome Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Sicca Syndrome Drug Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Sicca Syndrome Drug Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Sicca Syndrome Drug Revenue Market Share by Region (2021-2026) Table 66. Global Sicca Syndrome Drug Revenue Market Share by Region (2027-2032) Table 67. Novartis AG Company Information Table 68. Novartis AG Business Overview Table 69. Novartis AG Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Novartis AG Sicca Syndrome Drug Product Portfolio Table 71. Novartis AG Recent Development Table 72. GlaxoSmithKline Plc Company Information Table 73. GlaxoSmithKline Plc Business Overview Table 74. GlaxoSmithKline Plc Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Plc Sicca Syndrome Drug Product Portfolio Table 76. GlaxoSmithKline Plc Recent Development Table 77. Biogen, Inc. Company Information Table 78. Biogen, Inc. Business Overview Table 79. Biogen, Inc. Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Biogen, Inc. Sicca Syndrome Drug Product Portfolio Table 81. Biogen, Inc. Recent Development Table 82. Amgen Inc. Company Information Table 83. Amgen Inc. Business Overview Table 84. Amgen Inc. Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Amgen Inc. Sicca Syndrome Drug Product Portfolio Table 86. Amgen Inc. Recent Development Table 87. UCB S.A. Company Information Table 88. UCB S.A. Business Overview Table 89. UCB S.A. Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. UCB S.A. Sicca Syndrome Drug Product Portfolio Table 91. UCB S.A. Recent Development Table 92. Toleranzia AB Company Information Table 93. Toleranzia AB Business Overview Table 94. Toleranzia AB Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Toleranzia AB Sicca Syndrome Drug Product Portfolio Table 96. Toleranzia AB Recent Development Table 97. Redx Pharma Plc Company Information Table 98. Redx Pharma Plc Business Overview Table 99. Redx Pharma Plc Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Redx Pharma Plc Sicca Syndrome Drug Product Portfolio Table 101. Redx Pharma Plc Recent Development Table 102. MedImmune, LLC Company Information Table 103. MedImmune, LLC Business Overview Table 104. MedImmune, LLC Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. MedImmune, LLC Sicca Syndrome Drug Product Portfolio Table 106. MedImmune, LLC Recent Development Table 107. Bristol-Myers Squibb Company Company Information Table 108. Bristol-Myers Squibb Company Business Overview Table 109. Bristol-Myers Squibb Company Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Bristol-Myers Squibb Company Sicca Syndrome Drug Product Portfolio Table 111. Bristol-Myers Squibb Company Recent Development Table 112. Ampio Pharmaceuticals, Inc. Company Information Table 113. Ampio Pharmaceuticals, Inc. Business Overview Table 114. Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Product Portfolio Table 116. Ampio Pharmaceuticals, Inc. Recent Development Table 117. Akari Therapeutics, Plc Company Information Table 118. Akari Therapeutics, Plc Business Overview Table 119. Akari Therapeutics, Plc Sicca Syndrome Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Akari Therapeutics, Plc Sicca Syndrome Drug Product Portfolio Table 121. Akari Therapeutics, Plc Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Sicca Syndrome Drug Distributors List Table 125. Sicca Syndrome Drug Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Sicca Syndrome Drug Product Image Figure 2. Global Sicca Syndrome Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sicca Syndrome Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Sicca Syndrome Drug Sales (2021-2032) & (W Units) Figure 5. Global Sicca Syndrome Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sicca Syndrome Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. BMS-986142 Image Figure 9. Coversin Image Figure 10. Filgotinib Image Figure 11. Belimumab Image Figure 12. LY-3090106 Image Figure 13. Others Image Figure 14. Global Sicca Syndrome Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Sicca Syndrome Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Sicca Syndrome Drug Sales Market Share by Type (2021-2032) Figure 17. Global Sicca Syndrome Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 18. Global Sicca Syndrome Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Sicca Syndrome Drug Revenue Market Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Sicca Syndrome Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Sicca Syndrome Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Sicca Syndrome Drug Sales Market Share by Application (2021-2032) Figure 26. Global Sicca Syndrome Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 27. Global Sicca Syndrome Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Sicca Syndrome Drug Revenue Market Share by Application (2021-2032) Figure 29. North America Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 30. North America Sicca Syndrome Drug Sales Market Share by Country (2021-2032) Figure 31. U.S. Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Canada Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Mexico Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Europe Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Sicca Syndrome Drug Sales Market Share by Country (2021-2032) Figure 36. Germany Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 37. France Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 38. U.K. Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Italy Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Netherlands Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Asia Pacific Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Sicca Syndrome Drug Sales Market Share by Country (2021-2032) Figure 43. China Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Japan Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South Korea Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Southeast Asia Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 47. India Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Australia Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South America, Middle East and Africa Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Sicca Syndrome Drug Sales Market Share by Country (2021-2032) Figure 51. Brazil Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 52. South Africa Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Saudi Arabia Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Turkey Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Argentina Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 56. UAE Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Egypt Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Chile Sicca Syndrome Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Global Sicca Syndrome Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Sicca Syndrome Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Sicca Syndrome Drug Revenue (2021-2032) & (US$ Million) Figure 62. North America Sicca Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Sicca Syndrome Drug Revenue (2021-2032) & (US$ Million) Figure 64. Europe Sicca Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Sicca Syndrome Drug Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Sicca Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Sicca Syndrome Drug Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Sicca Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Sicca Syndrome Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Sicca Syndrome Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • BMS-986142
  • Coversin
  • Filgotinib
  • Belimumab
  • LY-3090106
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • GlaxoSmithKline Plc
  • Biogen, Inc.
  • Amgen Inc.
  • UCB S.A.
  • Toleranzia AB
  • Redx Pharma Plc
  • MedImmune, LLC
  • Bristol-Myers Squibb Company
  • Ampio Pharmaceuticals, Inc.
  • Akari Therapeutics, Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sicca Syndrome Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sicca Syndrome Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sicca Syndrome Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sicca Syndrome Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sicca Syndrome Drug Market Dynamics
  1. 2.1 Sicca Syndrome Drug Industry Trends
  2. 2.2 Sicca Syndrome Drug Industry Drivers
  3. 2.3 Sicca Syndrome Drug Industry Opportunities and Challenges
  4. 2.4 Sicca Syndrome Drug Industry Restraints
3 Sicca Syndrome Drug Market by Manufacturers
  1. 3.1 Global Sicca Syndrome Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sicca Syndrome Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sicca Syndrome Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sicca Syndrome Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sicca Syndrome Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sicca Syndrome Drug Manufacturers, Product Type & Application
  7. 3.7 Global Sicca Syndrome Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sicca Syndrome Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sicca Syndrome Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sicca Syndrome Drug Tier 1, Tier 2, and Tier 3
4 Sicca Syndrome Drug Market by Type
  1. 4.1 Sicca Syndrome Drug Type Introduction
  2. 4.1.1 BMS-986142
  3. 4.1.2 Coversin
  4. 4.1.3 Filgotinib
  5. 4.1.4 Belimumab
  6. 4.1.5 LY-3090106
  7. 4.1.6 Others
  8. 4.2 Global Sicca Syndrome Drug Sales by Type
  9. 4.2.1 Global Sicca Syndrome Drug Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Sicca Syndrome Drug Sales by Type (2021-2032)
  11. 4.2.3 Global Sicca Syndrome Drug Sales Market Share by Type (2021-2032)
  12. 4.3 Global Sicca Syndrome Drug Revenue by Type
  13. 4.3.1 Global Sicca Syndrome Drug Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Sicca Syndrome Drug Revenue by Type (2021-2032)
  15. 4.3.3 Global Sicca Syndrome Drug Revenue Market Share by Type (2021-2032)
5 Sicca Syndrome Drug Market by Application
  1. 5.1 Sicca Syndrome Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Sicca Syndrome Drug Sales by Application
  6. 5.2.1 Global Sicca Syndrome Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sicca Syndrome Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Sicca Syndrome Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Sicca Syndrome Drug Revenue by Application
  10. 5.3.1 Global Sicca Syndrome Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sicca Syndrome Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Sicca Syndrome Drug Revenue Market Share by Application (2021-2032)
6 Global Sicca Syndrome Drug Sales by Region
  1. 6.1 Global Sicca Syndrome Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sicca Syndrome Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Sicca Syndrome Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Sicca Syndrome Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sicca Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sicca Syndrome Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sicca Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sicca Syndrome Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sicca Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sicca Syndrome Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sicca Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sicca Syndrome Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sicca Syndrome Drug Revenue by Region
  1. 7.1 Global Sicca Syndrome Drug Revenue by Region
  2. 7.1.1 Global Sicca Syndrome Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sicca Syndrome Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Sicca Syndrome Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Sicca Syndrome Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sicca Syndrome Drug Revenue (2021-2032)
  8. 7.2.2 North America Sicca Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sicca Syndrome Drug Revenue (2021-2032)
  11. 7.3.2 Europe Sicca Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sicca Syndrome Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sicca Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sicca Syndrome Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sicca Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Sicca Syndrome Drug Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 GlaxoSmithKline Plc
  8. 8.2.1 GlaxoSmithKline Plc Company Information
  9. 8.2.2 GlaxoSmithKline Plc Business Overview
  10. 8.2.3 GlaxoSmithKline Plc Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Plc Sicca Syndrome Drug Product Portfolio
  12. 8.2.5 GlaxoSmithKline Plc Recent Developments
  13. 8.3 Biogen, Inc.
  14. 8.3.1 Biogen, Inc. Company Information
  15. 8.3.2 Biogen, Inc. Business Overview
  16. 8.3.3 Biogen, Inc. Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biogen, Inc. Sicca Syndrome Drug Product Portfolio
  18. 8.3.5 Biogen, Inc. Recent Developments
  19. 8.4 Amgen Inc.
  20. 8.4.1 Amgen Inc. Company Information
  21. 8.4.2 Amgen Inc. Business Overview
  22. 8.4.3 Amgen Inc. Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Inc. Sicca Syndrome Drug Product Portfolio
  24. 8.4.5 Amgen Inc. Recent Developments
  25. 8.5 UCB S.A.
  26. 8.5.1 UCB S.A. Company Information
  27. 8.5.2 UCB S.A. Business Overview
  28. 8.5.3 UCB S.A. Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 UCB S.A. Sicca Syndrome Drug Product Portfolio
  30. 8.5.5 UCB S.A. Recent Developments
  31. 8.6 Toleranzia AB
  32. 8.6.1 Toleranzia AB Company Information
  33. 8.6.2 Toleranzia AB Business Overview
  34. 8.6.3 Toleranzia AB Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Toleranzia AB Sicca Syndrome Drug Product Portfolio
  36. 8.6.5 Toleranzia AB Recent Developments
  37. 8.7 Redx Pharma Plc
  38. 8.7.1 Redx Pharma Plc Company Information
  39. 8.7.2 Redx Pharma Plc Business Overview
  40. 8.7.3 Redx Pharma Plc Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Redx Pharma Plc Sicca Syndrome Drug Product Portfolio
  42. 8.7.5 Redx Pharma Plc Recent Developments
  43. 8.8 MedImmune, LLC
  44. 8.8.1 MedImmune, LLC Company Information
  45. 8.8.2 MedImmune, LLC Business Overview
  46. 8.8.3 MedImmune, LLC Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MedImmune, LLC Sicca Syndrome Drug Product Portfolio
  48. 8.8.5 MedImmune, LLC Recent Developments
  49. 8.9 Bristol-Myers Squibb Company
  50. 8.9.1 Bristol-Myers Squibb Company Company Information
  51. 8.9.2 Bristol-Myers Squibb Company Business Overview
  52. 8.9.3 Bristol-Myers Squibb Company Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bristol-Myers Squibb Company Sicca Syndrome Drug Product Portfolio
  54. 8.9.5 Bristol-Myers Squibb Company Recent Developments
  55. 8.10 Ampio Pharmaceuticals, Inc.
  56. 8.10.1 Ampio Pharmaceuticals, Inc. Company Information
  57. 8.10.2 Ampio Pharmaceuticals, Inc. Business Overview
  58. 8.10.3 Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Product Portfolio
  60. 8.10.5 Ampio Pharmaceuticals, Inc. Recent Developments
  61. 8.11 Akari Therapeutics, Plc
  62. 8.11.1 Akari Therapeutics, Plc Company Information
  63. 8.11.2 Akari Therapeutics, Plc Business Overview
  64. 8.11.3 Akari Therapeutics, Plc Sicca Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Akari Therapeutics, Plc Sicca Syndrome Drug Product Portfolio
  66. 8.11.5 Akari Therapeutics, Plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sicca Syndrome Drug Value Chain Analysis
  2. 9.1.1 Sicca Syndrome Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sicca Syndrome Drug Production Mode & Process
  6. 9.2 Sicca Syndrome Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sicca Syndrome Drug Distributors
  9. 9.2.3 Sicca Syndrome Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst